Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are AvailableMatthias Samwald, Richard D. Boyce, Hong Xu et al.|PLoS ONE|2016Cited by 81
Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in childrenRobert S. B. Clark, Michael J. Bell, Philip E. Empey et al.|PLoS ONE|2017Cited by 56
Paths to Successful Translation of New Therapies for Severe Traumatic Brain Injury in the Golden Age of Traumatic Brain Injury Research: A Pittsburgh VisionPatrick M. Kochanek, C. Edward Dixon, Travis C. Jackson et al.|Journal of Neurotrauma|2018Cited by 54
Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric PatientsLaura B. Ramsey, Henry H. Ong, Jonathan S. Schildcrout et al.|JAMA Network Open|2020Cited by 49
A common flanking variant is associated with enhanced stability of the FGF14-SCA27B repeat locusDavid Pellerin, Sarah Fazal, Hong Jiang et al.|Nature Genetics|2024Cited by 34